Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation

European Journal of Haematology

Volumn 94, Issue 3, 2015, Pages 235-242

  Dadwal, Sanjeet S ^a   Tegtmeier, Bernard ^a   Liu, Xueli ^a   Frankel, Paul ^a   Ito, James ^a   Forman, Stephen J ^a   Pullarkat, Vinod ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Allogeneic stem cell transplant; Ferritin; Infection; Invasive mold; Iron overload

Indexed keywords

FERRITIN; IRON;

ACUTE LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLUS; BONE MARROW DEPRESSION; EVENT FREE SURVIVAL; FEMALE; FERRITIN BLOOD LEVEL; FUNGUS GROWTH; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION RISK; INVASIVE MOLD INFECTION; IRON OVERLOAD; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOMA; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SYSTEMIC MYCOSIS; UNRELATED DONORS; ADOLESCENT; ADVERSE EFFECTS; ALLOTRANSPLANTATION; ASPERGILLOSIS; BLOOD; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MYCOSES; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; AGED; ASPERGILLOSIS; FEMALE; FERRITINS; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IRON; IRON OVERLOAD; MALE; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84923271659     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12421     Document Type: Article

References (19)

1. Pullarkat V, Blanchard S, Tegtmeier B, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2008;42:799-805.
2. Tachibana T, Tanaka M, Takasaki H, et al. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies. J Hematol 2011;93:368-74.
3. Bullen JJ, Rogers HJ, Spadling PB, Ward CG. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol 2006;55:251-8.
4. Schaible UE, Kaufman SHE. Iron and microbial infection. Nat Rev 2004;2:946-54.
5. Altes A, Remacha AF, Sarda P, et al. Frequent severe iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004;34:505-9.
6. Kontoyiannis DP, Chamilos G, Lewis RE, et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 2007;110:1303-6.
7. Maertens J, Demuynck H, Verbeken EK, et al. Mucormycosis in allogeneic bone marrow transplant recipients: report of 5 cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999;24:307-12.
8. Ozyilmaz E, Aydogdu M, Sucak G, et al. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload. Bone Marrow Transplant 2010;45:1528-33.
9. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
10. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
11. Fine JP, Gray RJ. A proportional hazards model for the sub distribution of a competing risk. JASA 1999;94:496-509.
12. Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: Biologic Risk factors for infection according to time after transplantation. Clin Infect Dis 2008;47:1041-50.
13. Armand P, Kim HT, Rhodes J, et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Bone Marrow Transplant 2011;17:852-60.
14. Gordon LI, Brown SG, Tallman MS, et al. Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: Possible implications for treatment of related toxicity. Free Radical Biol Med 1995;18:383-9.
15. Sahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, Ruutu T. Non transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol 2001;113:836-8.
16. Bradley S, Gosriwitana I, Srichairatanakool S, Hider R, Porter J. Non transferrin bound iron induced by myeloablative chemotherapy. Br J Haematol 1997;99:337-43.
17. Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis 2008;21:620-5.
18. Spellberg B, Ibrahim AS, Chin-Hong PV, et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 2012;67:715-22.
19. Wingard JR, Carter SL, Walsh TJ, et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood 2010;116:5111-8.